Rhopoint Instruments: Net profit is expected to increase by 75% to 105% compared to the previous year in 2025.

On January 19, Ribo Instruments released its performance forecast, expecting a net profit attributable to shareholders of 2.84 billion to 3.32 billion in 2025, a year-on-year increase of 75% to 105%. In 2025, the company's overall operating income will steadily increase, especially with double-digit growth in the international market, with significant growth in patient monitoring and ultrasound imaging businesses.